•
Dec 31, 2020

CME Group Q4 2020 Earnings Report

CME Group's financial performance for Q4 2020 was reported, showing revenue of $1.1 billion and operating income of $515 million.

Key Takeaways

CME Group reported Q4 2020 revenue of $1.1 billion and operating income of $515 million. Net income was $424 million, with diluted earnings per share at $1.18. Adjusted net income was $497 million, and adjusted diluted earnings per share were $1.39.

CME Group remained focused on helping clients manage risk during the global pandemic.

The company achieved record international volume during full-year 2020.

Strong, double-digit, year-over-year growth was observed in the fourth quarter across Equity Index and Agricultural businesses.

The migration of BrokerTec business to CME Globex was completed, unlocking additional value and cost efficiencies.

Total Revenue
$1.1B
Previous year: $1.14B
-3.4%
EPS
$1.39
Previous year: $1.52
-8.6%
Average Daily Volume
16.23M
Previous year: 16.87M
-3.8%
Average Rate Per Contract
$0.699
Previous year: $0.717
-2.5%
Gross Profit
$883M
Previous year: $921M
-4.1%
Cash and Equivalents
$1.63B
Previous year: $1.55B
+5.3%
Free Cash Flow
$590M
Previous year: $653M
-9.6%
Total Assets
$125B
Previous year: $75.2B
+65.7%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group will continue to deliver innovative products that can address our clients' evolving needs, including Q1 launches for Ether futures, Global Emissions Offset futures and Japanese energy futures.

Revenue & Expenses

Visualization of income flow from segment revenue to net income